Systematic review of self-reported cognitive function in cancer patients following chemotherapy treatment
- 624 Downloads
Cognitive symptoms are common in cancer patients, with up to 70% reporting cognitive symptoms following chemotherapy. These symptoms can have a major impact on how an individual functions in all aspects of their lives. This review evaluates self-reported cognitive function and its associations with neuropsychological tests and patient-reported outcomes in adult cancer patients who received chemotherapy treatment for a solid cancer.
A search of multiple databases (Medline, Ovid at Nursing, PsycINFO, Allied and Complementary Medicine) from 1936 to 2017 was conducted, identifying 1563 unique articles, of which 101 met inclusion criteria.
Of the 101 included studies, 48 (47%) were cross-sectional and 38 (38%) longitudinal in design, with 12 (12%) randomised controlled trials. A minority (26%) incorporated a healthy control arm in the study design, whilst the majority (79%) were in women with breast cancer. There was diversity in the assessment of self-reported cognitive symptoms. A total of 43 of 44 studies that sought an association between self-reported cognitive function and patient-reported outcomes found a moderate to strong association. Overall, 31 studies showed a lack of association between self-reported cognitive symptoms and neuropsychological results, whilst 14 studies reported a significant association between the two, but the association was often restricted to limited cognitive domains.
The review found widespread heterogeneity in the assessment of self-reported cognitive symptoms and consistently absent or weak association with neuropsychological test scores.
Implications for Cancer Survivors
This research highlights the need for a standardised approach to measurement of self-reported cognitive symptoms in cancer patients.
KeywordsCancer Cognition Chemotherapy Self-reported cognitive function Cognitive symptoms
We acknowledge the following members of the research team for their contribution in data abstraction: Corrinne Renton (research officer); Doug Williams (research assistant); and undergraduate psychology students, Liam Darby, Charlotte Emily Davies, Christopher Mo, Pranathi Suryaprakash, Emily Jane Coombs Tidball and Maria Truasheim. We acknowledge Erika Jungfer (volunteer) for her contribution to obtaining articles and compilation of the endnote library.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
This review does not contain any studies with human participants performed by any of the authors.
- 8.Wagner L, Sweet J, Butt Z, et al. Measuring patient self-reported cognitive function: development of the Functional Assessment of Cancer Therapy - Cognitive Function instrument. The Journal of Supportive Oncology. 2009;7:W32–9.Google Scholar
- 9.Joly F, Giffard B, Rigal O, de Ruiter MB, Small BJ, Dubois M, et al. Impact of cancer and its treatments on cognitive function: advances in research from the Paris International Cognition and Cancer Task Force symposium and update since 2012. J Pain Symptom Manag. 2015;50:830–41.CrossRefGoogle Scholar
- 20.Kmet LML, Robert C.; Cook, Linda S. Standard quality assessment criteria for evaluating primary research papers from a variety of fields. Alberta Heritage Foundation for Medical Research 2004.Google Scholar
- 24.Amidi A, Christensen S, Mehlsen M, Jensen AB, Pedersen AD, Zachariae R. Long-term subjective cognitive functioning following adjuvant systemic treatment: 7-9 years follow-up of a nationwide cohort of women treated for primary breast cancer. Br J Cancer. 2015;113:794–801.PubMedPubMedCentralCrossRefGoogle Scholar
- 52.Fairbanks JMA. Longitudinal study of the effects of chemotherapy on cognitive functioning in breast cancer. Dissertation Abstracts International: Section B: The Sciences and Engineering. 2009;69:5799.Google Scholar
- 60.Hermelink K, Bühner M, Sckopke P et al. Chemotherapy and post-traumatic stress in the causation of cognitive dysfunction in breast cancer patients. JNCI: Journal of the National Cancer Institute 2017; 109: djx057-djx057.Google Scholar
- 61.Hess LM, Huang HQ, Hanlon AL, Robinson WR, Johnson R, Chambers SK, et al. Cognitive function during and six months following chemotherapy for front-line treatment of ovarian, primary peritoneal or fallopian tube cancer: an NRG oncology/gynecologic oncology group study. Gynecol Oncol. 2015;139:541–5.PubMedPubMedCentralCrossRefGoogle Scholar
- 64.Janelsins MC, Heckler CE, Peppone LJ, Kamen C, Mustian KM, Mohile SG, et al. Cognitive complaints in survivors of breast cancer after chemotherapy compared with age-matched controls: an analysis from a nationwide, multicenter, prospective longitudinal study. J Clin Oncol. 2017;35:506–14.PubMedCrossRefGoogle Scholar
- 80.Mandelblatt JS, Clapp JD. Long-term trajectories of self-reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance). 2016.Google Scholar
- 81.Mehnert A, Scherwath A, Schirmer L, Schleimer B, Petersen C, Schulz-Kindermann F, et al. The association between neuropsychological impairment, self-perceived cognitive deficits, fatigue and health related quality of life in breast cancer survivors following standard adjuvant versus high-dose chemotherapy. Patient Educ Couns. 2007;66:108–18.PubMedCrossRefGoogle Scholar
- 102.Schilder CM, Eggens PC, Seynaeve C, Linn SC, Boogerd W, Gundy CM, et al. Neuropsychological functioning in postmenopausal breast cancer patients treated with tamoxifen or exemestane after AC-chemotherapy: cross-sectional findings from the neuropsychological TEAM-side study. Acta Oncol. 2009;48:76–85.PubMedCrossRefGoogle Scholar
- 117.Vardy JL, Dhillon H, Xu W et al. Cognitive function and fatigue in colorectal cancer (CRC) patients: baseline assessments prior to chemotherapy. In ASCO Meeting Abstracts. Chicago, USA: 2009; 9557.Google Scholar
- 120.Galantino ML, Greene L, Daniels L, Dooley B, Muscatello L, O’Donnell L. Longitudinal impact of yoga on chemotherapy-related cognitive impairment and quality of life in women with early stage breast cancer: a case series. Explore: The Journal of Science & Healing. 2012;8:127–35.CrossRefGoogle Scholar